Cite
MLA Citation
Michael Silverman et al.. “A single‐ and multiple‐ascending dose study to evaluate the safety and pharmacokinetics of oral PU‐AD, an epichaperome inhibitor to treat Alzheimer's disease.” Alzheimer's & dementia, vol. 16, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100115142114.0x000036